BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23556477)

  • 1. 1H-NMR based metabonomic profiling of human esophageal cancer tissue.
    Wang L; Chen J; Chen L; Deng P; Bu Q; Xiang P; Li M; Lu W; Xu Y; Lin H; Wu T; Wang H; Hu J; Shao X; Cen X; Zhao YL
    Mol Cancer; 2013 Apr; 12():25. PubMed ID: 23556477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ¹H NMR-based metabolic profiling of human rectal cancer tissue.
    Wang H; Wang L; Zhang H; Deng P; Chen J; Zhou B; Hu J; Zou J; Lu W; Xiang P; Wu T; Shao X; Li Y; Zhou Z; Zhao YL
    Mol Cancer; 2013 Oct; 12(1):121. PubMed ID: 24138801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Li Y; Wang C; Li D; Deng P; Shao X; Hu J; Liu C; Jie H; Lin Y; Li Z; Qian X; Zhang H; Zhao Y
    Oncol Rep; 2017 Nov; 38(5):3044-3054. PubMed ID: 28901465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
    Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
    BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
    Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
    World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
    Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
    Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealing the metabonomic variation of EC using ¹H-NMR spectroscopy and its association with the clinicopathological characteristics.
    Hasim A; Ma H; Mamtimin B; Abudula A; Niyaz M; Zhang LW; Anwer J; Sheyhidin I
    Mol Biol Rep; 2012 Sep; 39(9):8955-64. PubMed ID: 22736106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy.
    Shao W; Gu J; Huang C; Liu D; Huang H; Huang Z; Lin Z; Yang W; Liu K; Lin D; Ji T
    Mol Cancer; 2014 Aug; 13():197. PubMed ID: 25163530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients.
    Yakoub D; Keun HC; Goldin R; Hanna GB
    Cancer Res; 2010 Nov; 70(22):9129-36. PubMed ID: 20884633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolomic signature of esophageal cancer and Barrett's esophagus.
    Davis VW; Schiller DE; Eurich D; Sawyer MB
    World J Surg Oncol; 2012 Dec; 10():271. PubMed ID: 23241138
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ye W; Lin Y; Bezabeh T; Ma C; Liang J; Zhao J; Ouyang T; Tang W; Wu R
    NMR Biomed; 2021 Jun; 34(6):e4505. PubMed ID: 33783927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1H-MRS metabonomic analysis of plasma samples of esophageal cancer patients based on different pattern recognition].
    Ayshamgul H; Batur M; Ilyar S
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):681-4. PubMed ID: 21122383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.
    Zhang J; Bowers J; Liu L; Wei S; Gowda GA; Hammoud Z; Raftery D
    PLoS One; 2012; 7(1):e30181. PubMed ID: 22291914
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Akhtar MT; Samar M; Shami AA; Mumtaz MW; Mukhtar H; Tahir A; Shahzad-Ul-Hussan S; Chaudhary SU; Kaka U
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.
    Lin X; Zhan B; Wen S; Li Z; Huang H; Feng J
    Mol Biosyst; 2016 Aug; 12(9):2883-92. PubMed ID: 27400832
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Liu YY; Yang ZX; Ma LM; Wen XQ; Ji HL; Li K
    PeerJ; 2019; 7():e8151. PubMed ID: 31803539
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.